Indian Express | Outside the patent monopolies Indian Express Novartis's drug Glivec was denied patent protection by the Supreme Court and India granted a compulsory licence to Bayer's drug Nexavar, which treats kidney and liver cancer. Compulsory licences are a provision in international patent norms, including ... |
